Literature DB >> 1691079

The effects of altered retinal vascular perfusion pressure on the white flash scotopic ERG and oscillatory potentials in man.

H Kergoat1, J V Lovasik.   

Abstract

The oscillatory potentials (OPs) of the flash-elicited electroretinogram b-wave have been identified as sensitive indices of abnormalities within the retinal circulation. A recent study by Lovasik and Kothe has identified the rod system as being more vulnerable than the cone system to transient alterations of the retinal vascular perfusion pressure (RVPP). In view of these previous findings, we investigated the susceptibility of the scotopic OPs to altered retinal perfusion, in 10 normotensive paid volunteers between 21 and 31 years of age. A transient increase in RVPP was effected by body inversion, while a transient decrease in RVPP was obtained by suction ophthalmodynamometry. Group averaged data showed that OP-1 to OP-4 decreased in amplitude with either an increase or a decrease in RVPP. In contrast to all other OPs, OP-5 was reduced to a greater degree when RVPP was decreased and showed a pronounced gain in amplitude as RVPP was increased. Our study has isolated a component-specific vulnerability to altered retinal perfusion. This finding may be interpreted as indicating a different retinal site of origin for the generators of OP-5. The heightened sensitivity of OP-5 to alteration of the RVPP may offer diagnostic advantage for investigating chronic diseases causing retinal ischemia.

Entities:  

Mesh:

Year:  1990        PMID: 1691079     DOI: 10.1016/0013-4694(90)90109-w

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  8 in total

1.  Extraction and modeling of the Oscillatory Potential: signal conditioning to obtain minimally corrupted Oscillatory Potentials.

Authors:  Peter H Derr; Andrew U Meyer; Edward J Haupt; Mitchell G Brigell
Journal:  Doc Ophthalmol       Date:  2002-01       Impact factor: 2.379

2.  Electrophysiological evaluation of visual pathways in paclitaxel-treated patients.

Authors:  V Scaioli; A Caraceni; C Martini; S Curzi; G Capri; G Luca
Journal:  J Neurooncol       Date:  2005-08-25       Impact factor: 4.130

3.  Retinal oscillatory potential abnormalities in patients with chronic renal failure, before and after dialytic treatment.

Authors:  A Polo; L Lazzarino; F Pitzorno; E Beltram; G Zanette; D de Grandis
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

4.  Differential effects of compression and suction ophthalmodynamometry on the scotopic blue-flash electroretinogram.

Authors:  J V Lovasik; A C Kothe; H Kergoat
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

5.  Pigmented and albino rats differ in their responses to moderate, acute and reversible intraocular pressure elevation.

Authors:  Akshay Gurdita; Bingyao Tan; Karen M Joos; Kostadinka Bizheva; Vivian Choh
Journal:  Doc Ophthalmol       Date:  2017-04-07       Impact factor: 2.379

6.  PACAP application improves functional outcome of chronic retinal ischemic injury in rats-evidence from electroretinographic measurements.

Authors:  Bese Danyadi; Krisztina Szabadfi; Dora Reglodi; Agoston Mihalik; Tibor Danyadi; Zsolt Kovacs; Istvan Batai; Andrea Tamas; Peter Kiss; Gabor Toth; Robert Gabriel
Journal:  J Mol Neurosci       Date:  2014-04-11       Impact factor: 3.444

7.  Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype.

Authors:  Timm Schubert; Corinna Gleiser; Peter Heiduschka; Christoph Franz; Kerstin Nagel-Wolfrum; Ayse Sahaboglu; Nicole Weisschuh; Gordon Eske; Karin Rohbock; Norman Rieger; François Paquet-Durand; Bernd Wissinger; Uwe Wolfrum; Bernhard Hirt; Wibke Singer; Lukas Rüttiger; Ulrike Zimmermann; Marlies Knipper
Journal:  Cell Mol Life Sci       Date:  2015-05-06       Impact factor: 9.261

8.  Electrophysiological function of the retina and optic nerve in patients with atrial fibrillation.

Authors:  Michal Post; Wojciech Goslawski; Monika Modrzejewska; Maciej Wielusinski; Jaroslaw Kazmierczak; Wojciech Lubinski
Journal:  Doc Ophthalmol       Date:  2015-04-25       Impact factor: 2.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.